Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Synergy CHC Corp. (SNYR : NSDQ)

• Company Description    Synergy CHC Corp. is a provider of consumer health care, beauty and lifestyle products. The company's current brand portfolio consists of marquee brands, FOCUSfactor, a clinically-tested brain health supplement and Flat Tummy, a lifestyle and wellness brand which provides a suite of nutritional products to help women achieve their weight management goals. Synergy CHC Corp. is based in Westbrook, Maine. Number of Employees: 28

• Price / Volume Information    Yesterday's Closing Price: $0.25 Daily Weekly Monthly 20 Day Moving Average: 875,466 shares Shares Outstanding: 15.08 (millions) Market Capitalization: $3.85 (millions) Beta: -0.26 52 Week High: $4.00 52 Week Low: $0.24 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -36.23% -39.35% 12 Week -80.38% -81.87% Year To Date -86.29% -87.67%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 770 Roosevelt Trail STE 8 #1016 - N. Windham,ME 04062 USA ph: 207-321-2350 fax: - snyr@gateway-grp.com http://www.synergychc.com

• General Corporate Information    Officers Jack Ross - Chief Executive Officer and Chairman Jaime Fickett - Chief Financial Officer Alfred Baumeler - Director J. Paul SoRelle - Director Nitin Kaushal - Director Peer Information Synergy CHC Corp. (CHCR) Synergy CHC Corp. (ESRX) Synergy CHC Corp. (MYDP) Synergy CHC Corp. (COR) Synergy CHC Corp. (GBCS) Synergy CHC Corp. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 87165D208 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 15.08 Most Recent Split Date: (:1) Beta: -0.26 Market Capitalization: $3.85 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.04 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.13 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: 1.96 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 0.15 EPS Growth vs. Year Ago Period: -330.00% vs. Previous Quarter: 25.81% Sales Growth vs. Year Ago Period: -32.77% vs. Previous Quarter: -9.43% ROE 03/31/26 - - 12/31/25 - - 09/30/25 - -19.51 ROA 03/31/26 - -30.30 12/31/25 - -5.29 09/30/25 - 14.25 Current Ratio 03/31/26 - 0.93 12/31/25 - 1.22 09/30/25 - 5.35 Quick Ratio 03/31/26 - 0.43 12/31/25 - 0.76 09/30/25 - 4.79 Operating Margin 03/31/26 - -16.43 12/31/25 - -3.02 09/30/25 - 7.77 Net Margin 03/31/26 - -60.02 12/31/25 - -42.59 09/30/25 - 7.77 Pre-Tax Margin 03/31/26 - -59.58 12/31/25 - -40.24 09/30/25 - 8.23 Book Value 03/31/26 - -1.68 12/31/25 - -2.06 09/30/25 - -0.87 Inventory Turnover 03/31/26 - 3.30 12/31/25 - 3.81 09/30/25 - 4.67 Debt-to-Equity 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Capital 03/31/26 - - 12/31/25 - - 09/30/25 - -

Powered by Zacks Investment Research ©